Pain in leprosy patients: Shall we always consider as a neural damage?

Leprosy Review

Volumn 82, Issue 3, 2011, Pages 319-321

  Reis, Felipe J J ^a   Saadi, Licia M V ^a   Gomes, Maria K ^a   Gosling, Artur P ^a   Cunha, Antônio J L A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PREDNISONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; CHRONIC PAIN; DEFORMITY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISABILITY; HUMAN; LEPROSY; LETTER; MYCOBACTERIUM LEPRAE; MYOFASCIAL PAIN; NERVE LESION; NEURITIS; NEUROLYSIS; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PATHOGENICITY; PSYCHOLOGICAL ASPECT; SOCIAL ASPECT; SOCIAL ISOLATION; SOCIAL PSYCHOLOGY; SOCIAL STIGMA; UNSPECIFIED SIDE EFFECT;

HUMANS; LEPROSTATIC AGENTS; LEPROSY; NEURALGIA; PAIN;

EID: 80054729462     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (34)

1. Job CK. Pathology and pathogenesis of leprous neuritis: a prevalence and treatable complication. Int J Lepr Other Mycobact Dis, 2001; 69(Suppl): S19-S29.
2. Van Brakel WH, Khawas IB. Nerve damage in leprosy: an epidemiological and clinical study of 396 patients in west Nepal - Part 1. Definitions, methods and frequencies. Lepr Rev, 1994; 65: 204-221.
3. Rose P, Waters MF. Reversal reactions in leprosy and their management. Lepr Rev, 1991; 62: 113-121.
4. Lienhardt C, Fine PE. Type 1 reaction, neuritis and disability in leprosy: What is the current epidemiological situation? Lepr Rev, 1994; 65: 9-33.
5. Jiang J, Watson JM, Zhang GC, Wei XY. A field trial of detection and treatment of nerve function impairment in leprosy: report from national POD pilot project. Lepr Rev, 1998; 69: 367-375.
6. Van Brakel WH, Khawas IB. Silent neuropathy in leprosy: an epidemiological description. Lepr Rev, 1994; 65: 350-360.
7. Hietaharju A, Croft R, Alam R et al. Chronic neuropathic pain in treated leprosy. Lancet, 2000; 23; 356(9235): 1080-1081.
8. Stump PR, Baccarelli R, Marciano LH et al. Neuropathic pain in leprosy patients. Int J Lepr Other Mycobact Dis, 2004; 72: 134-138.
9. Little D, Khanolkar-Young S, Coulthart A et al. Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy Type 1 (reversal) reactions before and during prednisolone treatment. Infect Immun, 2001; 69: 3413-3417.
10. Naafs B. Treatment duration of reversal reaction: a reappraisal. Back to the past. Lepr Rev, 2003; 74: 328-336.
11. Boucher P, Millan J, Parent M, Moulia-Pela JP. Randomized controlled trial of medical and medico-surgical treatment of Hansen's neuritis. Acta Leprol, 1999; 11: 171-177.
12. Marlowe SN, Hawksworth RA, Butlin CR et al. Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy Type 1 reactions in Nepal. Trans R Soc Trop Med Hyg, 2004; 98: 602-609.
13. Haanpää M, Lockwood DN, Hietaharju A. Neuropathic pain in leprosy. Lepr Rev, 2004; 75: 7-18.
14. Lund C, Koskinen M, Suneetha S et al. Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India. Lepr Rev, 2007; 78: 369-380.
15. Saunderson P, Bizuneh E, Leekassa R. Neuropathic pain in people treated for multibacillary leprosy more than ten years previously. Lepr Rev, 2008; 79: 270-276.
16. Abrahams MJ. Neuropathic pain in soft tissue complaints. Best Pract Res Clin Rheumatol, 2007; 21: 223-244.
17. Cummings M, Baldry P. Regional myofascial pain: diagnosis and management. Best Pract Res Clin Rheumatol, 2007; 21: 367-387.
18. Skootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal medicine practice. West J Med, 1989; 151: 157-160.
19. Henriksson KG, Bäckman E, Henriksson C, de Laval JH. Chronic regional muscular pain in women with precise manipulation work. Scand J Rheumatol, 1996; 25: 213-223.
20. Sola AE, Rodenberger ML, Gettys PP. Incidence of hypersensitive areas in posterior shoulder muscles. Am J Phys Med, 1955; 34: 585-590.
21. Bennett R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol, 2007; 21: 427-445.
22. Travell J, Rinzler S, Herman M. Pain and disability of the shoulder and arm, treatment by intramuscular infiltration with procaine hydrochloride. JAMA, 1942; 120: 417-422.
23. Santos JG, Brito JO, de Andrade DC et al. Translation to Portuguese and Validation of the Douleur Neuropathique 4 Questionnaire. J Pain, 2010; 11: 484-490.
24. Bonica JJ. General considerations of chronic pain. In: Bonica JJ (ed). The management of pain. Lea and Febiger, Philadelphia, 1990.
25. Turk DC, Rudy TE. Toward an empirically derived taxonomy of chronic pain patients: integration of psychological assessment data. J Consult Clin Psychol, 1988; 56: 233-238.
26. Melzack R. Pain and the neuromatrix in the brain. J Dent Educ, 2001; 65: 1378-1382.
27. Melzack R. From the gate to the neuromatrix. Pain Suppl, 1999; 6: S121-S126.
28. Kröner-Herwig B. Chronic pain syndromes and their treatment by psychological interventions. Curr Opin Psychiatry, 2009; 22: 200-204.
29. Apkarian AV, Baliki MN, Geha PY. Towards a theory of chronic pain. Prog Neurobiol, 2009; 87: 81-97.
30. Oliveira JT. Behavioral aspects of chronic pain syndromes. Arq Neuropsiquiatr, 2000; 58: 360-365.
31. Schmidl F. Psychological concepts and treatments for chronic pain and somatoform syndromes. Wien Med Wochenschr, 2000; 150: 295-299.
32. Kautzsch K, Kopf A. Differential diagnosis of pain experience. Fortschr Med Orig, 2001; 118: 153-156.
33. Lasry-Levy E, Hietaharju A, Pai V et al. Neuropathic Pain and Psychological Morbidity in Patients with Treated Leprosy: A Cross-Sectional Prevalence Study in Mumbai. PLoS Negl Trop Dis, 2011; 5: e981.
34. Müller-Busch HC. The 'healthy pain patient'. Schmerz, 1990; 4: 179-183.